Navigation Links
Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S.
Date:3/2/2009

e your insulin may need to change if you take a different type of insulin.

Do not mix NovoLog(R) with any other insulins when used in a pump or with any insulins other than NPH when used with injections by syringe.

Do not take NovoLog(R) if your blood sugar is too low (hypoglycemia) or if you are allergic to anything in NovoLog(R). If you take too much NovoLog(R) your blood sugar may fall too low.

Tell your health care provider about all medicines you take and all of your medical conditions, including if you are pregnant or breastfeeding. Your NovoLog(R) dose may change if you take other medicines.

The most common side effect of insulin therapy, including NovoLog(R) is low blood sugar (hypoglycemia). Other possible side effects include reactions at the injection site (like redness, swelling, and itching) and allergic reactions. Get medical help right away if you experience signs of serious allergic reaction such as body rash, trouble with your breathing, fast heartbeat, or sweating. Ask your doctor or pharmacist for further information.

About NovoLog(R) Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])

NovoLog(R) Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a man-made insulin that is used to control high blood sugar in adults with diabetes mellitus.

Important Safety Information

NovoLog(R) Mix 70/30 is a pre-mixed insulin. You should eat a meal within 15 minutes after using NovoLog(R) Mix 70/30 to avoid low blood sugar. Do not inject NovoLog(R) Mix 70/30 if you are not planning to eat within 15 minutes. Check your blood glucose regularly. Ask your health care provider what your blood sugars should be and when you should check your blood sugar levels. Alcohol, including beer and wine, may affect your blood sugar when y
'/>"/>

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Photos: Jiffy Lube(R) Halfway Home in Drive to Fight Heart Disease with Maintenance Partners for Life Campaign
2. Photos: Medpedia Launches
3. Photos: Apples iPhone Finds New Use in Treating Stuttering at Hollins Communications Research Institute
4. Photos: Opalescence Treswhite Supreme Adds Glimmer to Twilight Film Actors Smile
5. Photos: Despite Widespread Awareness, Most Women Still Dont Feel at Risk for Cervical Cancer
6. Photos: Bring Back the Bread in Your Diet With Arnold(R) Select(TM) Sandwich Thins(TM) and Bakery Light(TM) Breads
7. Photos: TV Soap Opera Veteran Speaks Out to Lead Charge to Cure Digestive Diseases
8. Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis
9. Photos: Ifrenel s.a. Acne Skin Therapy Offers a Revolutionary New Solution For Fighting Problem Skin
10. Photos: U.S. Food and Drug Administration Issues No Objection Letter to GRAS Status of Rebaudioside A
11. Photos: Changing Behavior, One Woman at a Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Dennis Thompson HealthDay ... Babies born early or at low birth weight are at ... or health problems that increase their risk for heart disease, ... though these children face potential lifetime disadvantages, researchers in ... -- found that these obstacles can be overcome. ...
(Date:9/2/2014)... News) -- When it comes to excess pounds and blood ... study finds. The research found that belly fat -- ... high blood pressure more than overall body fat. It,s ... pressure. But it wasn,t clear how the location of fat ... University of Texas Southwestern Medical Center in Dallas. Reporting ...
(Date:9/2/2014)... Moroccan Eco-Biologics’ new one-of-a-kind Vitality Hair Recovery ... the foundation of all natural Moroccan plant extracts to ... There is nothing similar to Vitality Hair Recovery cream ... is a commonly encountered problem for men and women ... been limited to existing medications offering mediocre results, considerable ...
(Date:9/2/2014)... 2014 National law firm, ... has filed an application for attorneys’ fees and ... action litigation brought over Flushmate flushing mechanisms. In ... Counsel in this litigation includes Birka-White Law Offices; ... Partners, LLP; Levin Fishbein, Sedran & Berman, LLP; ...
(Date:9/2/2014)... Florida (PRWEB) September 02, 2014 ... Accredited teleradiology and telemedicine solutions provider, including SecondOpinions.com® ... its innovative and technologically advanced services. The telemedicine ... Shifa Hospital in Kuwait. , Founded and established ... Kuwait, Dar Al Shifa began as a maternity ...
Breaking Medicine News(10 mins):Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 2Health News:Preterm or Small Birth Tied to Long-Term Risks to Heart, Brain 3Health News:'Spare Tire' May Be Especially Bad for Your Blood Pressure 2Health News:New All Natural, Organic Hair Recovery Products by Moroccan Eco-Biologics, Restore Lost Hair with No Side Effects 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 2Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 3Health News:USARAD Holdings Inc. SECONDOPINIONS.COM® Partners With Prestigious Dar Al Shifa Hospital In Kuwait 4
... PhD, a physician-scientist in the Hematology/Oncology Divison at Beth ... at Harvard Medical School has received a Young Investigator ... $225,000 award, one of 21 made to young scientists ... encourage the most innovative minds in cancer research to ...
... years and younger living in Tanzania. With limited ... positive and significant impact on what these children learn? ... version of Sesame Street, recently commissioned researchers from the ... collaboration with a Dar es Salaam-based research team, to ...
... at the Stanford University School of Medicine have identified ... significant because the existence of such a cell in ... debate. It may also explain why current immunotherapies are ... "These cells lack the traditional melanoma cell ...
... ... mollis. Aenean cursus, nisi id congue convallis, risus augue pulvinar sem, nec ultricies nulla ... In placerat eleifend felis in commodo. , ... Freistatt, MO (PRWEB) June 30, 2010 -- Lorem ipsum dolor ...
... By Dennis Thompson HealthDay Reporter , WEDNESDAY, ... reached a point of significant potential, even as the disease,s ... say. Some leading scientists, in fact, worry that we ... advances and new insights into Alzheimer,s, the most common type ...
... improving the environment in life may soon be able to ... new and unusual methods of body disposal including a ... bodies into soil that could provide environmentally friendly alternatives ... article in the current issue of Chemical & Engineering News ...
Cached Medicine News:Health News:BIDMC researcher receives Young Investigator Award from Prostate Cancer Foundation 2Health News:Kilimani Sesame has positive impact on children in Tanzania: Johns Hopkins University study 2Health News:Melanoma-initiating cell identified by Stanford scientists 2Health News:Melanoma-initiating cell identified by Stanford scientists 3Health News:Melanoma-initiating cell identified by Stanford scientists 4Health News:Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce ornare dictum nunc 2Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 2Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 3Health News:Experts Optimistic About Solving Puzzle of Alzheimer's 4
(Date:9/2/2014)... ResMed (NYSE: RMD ) has introduced ... the United States . The Astral platform ... life support ventilators. ResMed,s new Astral ... use for patients suffering from neuromuscular disease, chronic obstructive ... disorders. The U.S. launch comes on the heels of ...
(Date:9/2/2014)... 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... Administration (FDA) has granted orphan drug status to APD811 ... "The FDA Office of Orphan Products Development (OOPD) ... identify and designate drug candidates that could potentially treat ... of such products," said Craig M. Audet , ...
(Date:9/2/2014)... 2014   Intrexon Corporation (NYSE: ... that it has entered into an Exclusive Channel Collaboration ... Sanofi (EURONEXT: SAN and NYSE: SNY ) ... family of its marketed Active Pharmaceutical Ingredients (APIs) through ... . This collaboration will leverage Intrexon,s proprietary technology suite ...
Breaking Medicine Technology:ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 2ResMed's Revolutionary Life Support Ventilation Platform -- Astral 100 and 150 Devices Now Available in the U.S. 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 2Intrexon Announces Exclusive Channel Collaboration with Sanofi to Optimize Production for a Specific Family of Active Pharmaceutical Ingredients 3
Inquire...
Inquire...
... The compact Allegra X-22 Series is up to ... With a library of 11 rotors, the Allegra X-22 ... Features: Only 18 inches / 46 ... to 22,065 x g 3 different ways to ...
... Fractionation, Proteins and Viruses • ... with fixed-angle rotor • Spin ... 85 mL • Operating temperature ... C • Rotors certified by ...
Medicine Products: